Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estradiol implants for conception control

C Nezhat, A E Karpas, R B Greenblatt

    American Journal of Obstetrics and Gynecology
    |December 15, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A proof of concept that experience-based management of endometriosis can complement evidence-based guidelines.

    Facts, views & vision in ObGyn·2023
    Same author

    Predictive factors and treatment of recurrence of endometriosis.

    Minerva ginecologica·2013
    Same author

    Laparoscopic surgery for gynecologic cancer.

    Surgical technology international·2011
    Same author

    Endometriosis of the intestine and genitourinary tract.

    Surgical technology international·2011
    Same author

    Menopausal arthritis.

    The Medical clinics of North America·2010
    Same author

    Treatment of granuloma inguinale with diramin; a new antimonial.

    The Journal of venereal disease information·2010
    Same journal

    Association of Surgical Approach with Oncologic Outcomes in Low-Risk Cervical Cancer.

    American journal of obstetrics and gynecology·2026
    Same journal

    Trends in Infertility Treatments by Race, Ethnicity, Socioeconomic Status, and Region in U.S. Birth Certificates from Live Births: 2011-2022.

    American journal of obstetrics and gynecology·2026
    Same journal

    Likelihood ratios enhance clinical interpretation of metagenomic prediction of early-onset neonatal sepsis in preterm premature rupture of membranes (Letter-to-the-Editor).

    American journal of obstetrics and gynecology·2026
    Same journal

    Taking risk stratification in preterm premature rupture of membranes to the bedside (Reply to Letter-to-the-Editor).

    American journal of obstetrics and gynecology·2026
    Same journal

    Gestational Age at Full-Term Delivery and Long-Term Offspring Morbidity in Low-Risk Pregnancies: A Population-Based Cohort Study.

    American journal of obstetrics and gynecology·2026
    Same journal

    Trajectories of childbirth-related posttraumatic stress symptoms after a vaginal delivery: a multicenter prospective study.

    American journal of obstetrics and gynecology·2026
    See all related articles

    Natural estrogen implants offer a safe alternative to oral contraceptives for women over 35, showing fewer side effects and effective conception control. This method proved highly acceptable for women unable to use traditional birth control pills.

    Area of Science:

    • Reproductive endocrinology
    • Pharmacology
    • Women's health

    Background:

    • Oral contraceptives are linked to serious adverse effects, particularly for women over 35.
    • Existing hormonal contraceptives may cause metabolic disturbances and side effects.
    • A need exists for safer, well-tolerated contraceptive options.

    Purpose of the Study:

    • To evaluate the safety and efficacy of natural estrogen (17 beta-estradiol) pellet implants as a contraceptive method.
    • To compare the metabolic and side effect profiles of estrogen implants versus oral contraceptives.
    • To assess the acceptability of estrogen implants in women who cannot tolerate oral contraceptives.

    Main Methods:

    • A cohort of 1,540 women contributed 18,480 cycles of data.

    Related Experiment Videos

  • 17 beta-estradiol pellets were implanted in descending doses every six months.
  • The corrected Pearl index was calculated to assess contraceptive efficacy.

    • Main Results:

    • The corrected Pearl index was 0.273, indicating high contraceptive efficacy comparable to other methods.
    • Estrogen pellet implants demonstrated fewer metabolic disturbances and side effects than oral contraceptives.
    • The implant method was well-accepted by women who previously experienced intolerance to oral contraceptives.

    Conclusions:

    • Natural estrogen (17 beta-estradiol) pellet implants provide a safe and effective alternative for conception control.
    • This method is particularly suitable for women over 35 and those intolerant to oral contraceptives.
    • Estrogen implants offer a favorable side effect profile and high user acceptability.